Kiniksa Pharmaceuticals International, plc KNSA

75.08 (0.26) (0.35%) as of 25 Sep
Market cap
$5.9B
P/E
70.2×
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio 51.56 0.00 97.53 5.47 0.00 — — — — —
P/S ratio 4.52 3.34 4.80 4.55 0.00 — — — — —
P/FCF ratio 22.42 55.34 97.89 177.86 0.00 — — — — —
P/Operating CF 56.79 75.27 300.16 (86.55) (42.74) — — — — —
P/B ratio 5.39 3.22 2.96 2.53 4.36 — — — — —
EV/Sales 3.91 2.76 4.04 3.68 0.00 — — — — —
EV/EBITDA 33.60 0.00 0.00 66.63 0.00 — — — — —
EV/FCF 19.39 45.80 82.33 144.02 (4.26) — — — — —
Current Ratio 3.79 3.30 4.34 5.16 4.38 10.46 8.68 7.37 2.70 24.47
Net Debt/EBITDA (5.26) 5.55 9.03 (15.66) 1.18 2.09 1.39 2.85 0.70 2.34
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 11.73% (9.85%) 3.37% 63.10% (63.55%) (60.06%) (64.15%) (108.91%) 112.39% 41.53%
ROA 8.78% (7.80%) 2.86% 52.96% (54.24%) (53.44%) (56.16%) (55.88%) (124.80%) (46.12%)
ROIC 31.44% (14.63%) (6.77%) 2.97% (3,451.96%) 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets 15.13% (18.63%) 6.60% 92.77% (102.25%) (52.83%) (73.51%) (37.19%) (217.70%) (44.30%)
Average Days of Receivables 8.40 35.98 28.72 20.99 37.74 — — — — —
Earnings Yield 1.94% (3.08%) 1.03% 18.28% (19.54%) — — — — —
Free Cash Flow Yield 4.46% 1.81% 1.02% 0.56% (18.18%) — — — — —
Free Cash Flow per Share 1.84 0.36 0.19 0.08 (2.14) (2.21) (2.99) (2.92) (27.78) (83.57)
Book value per Share 7.65 6.14 6.26 5.71 2.70 5.04 4.17 9.45 16.61 206.97
Free Cash Flow 136.42 25.44 13.17 5.79 (146.71) (136.81) (161.57) (86.30) (50.29) (21.87)
EV/EBIT 34.27 0.00 0.00 83.01 0.00 — — — — —
Other line items

Show all line items

Columns are period end dates